↓ Skip to main content

Cochrane Database of Systematic Reviews

Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
10 tweeters
f1000
1 research highlight platform

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
328 Mendeley
citeulike
1 CiteULike
Title
Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd003794.pub4
Pubmed ID
Authors

Luis Javier Nannini, Phillippa Poole, Stephen J Milan, Rebecca Holmes, Rebecca Normansell

Abstract

Both long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS) have been recommended in guidelines for the treatment of chronic obstructive pulmonary disease (COPD). Their coadministration in a combination inhaler may facilitate adherence to medication regimens and improve efficacy.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 328 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 <1%
Brazil 2 <1%
Chile 1 <1%
Indonesia 1 <1%
Netherlands 1 <1%
South Africa 1 <1%
Tunisia 1 <1%
Spain 1 <1%
United States 1 <1%
Other 0 0%
Unknown 316 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 57 17%
Researcher 45 14%
Student > Ph. D. Student 33 10%
Student > Bachelor 28 9%
Other 23 7%
Other 71 22%
Unknown 71 22%
Readers by discipline Count As %
Medicine and Dentistry 149 45%
Nursing and Health Professions 24 7%
Agricultural and Biological Sciences 13 4%
Social Sciences 13 4%
Pharmacology, Toxicology and Pharmaceutical Science 13 4%
Other 36 11%
Unknown 80 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2017.
All research outputs
#4,177,928
of 21,732,065 outputs
Outputs from Cochrane database of systematic reviews
#6,558
of 12,101 outputs
Outputs of similar age
#41,002
of 209,201 outputs
Outputs of similar age from Cochrane database of systematic reviews
#56
of 110 outputs
Altmetric has tracked 21,732,065 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,101 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.5. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,201 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.